HIGHLIGHTS
- who: Michael Davidson from the Pritzker SchoolUniversity of have published the article: Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib[S], in the Journal: (JOURNAL) of 25/09/2012
- what: In the current study, LDL-C and HDL-C were remeasured by several different assay methods using stored frozen serum samples obtained from 280 individuals in a patient subset at baseline and after 24 weeks of treatment with anacetrapib 100 mg daily in the DEFINE trial. The aim of this study was to evaluate different methods for measuring the concentration of LDL . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.